Although increasing numbers of studies have investigated the expression and functions of LIF within various cancers, there are still have limitation of clinical trials that explore a therapeutic agents aimed at affecting LIF signaling for improving outcomes for patients with cancers. The gene discussed is LIF; the disease is cancer.